Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 16, 2022; 10(17): 5634-5645
Published online Jun 16, 2022. doi: 10.12998/wjcc.v10.i17.5634
Table 2 Comparisons of positron emission tomography parameters among malignant, premalignant, malignant/premalignant, and benign lesions

Malignant (n = 24)
Premalignant (n = 27)
P value
mean SUVmax ± SD12.8 ± 7.610.5 ± 4.7> 0.05
mean SUVpeak ± SD9.7 ± 6.17.9 ± 4.0> 0.05
Malignant (n=24)Benign (n=32)P value
mean SUVmax ± SD12.8 ± 7.67.2 ± 3.4< 0.05
mean SUVpeak ± SD9.7 ± 6.15.6 ± 2.7< 0.05
mean mSUVmtv3.5 ± SD6.1 ± 1.84.7 ± 0.8< 0.05
Premalignant (n=27)Benign (n=32)P value
mean SUVmax ± SD10.5 ± 4.77.2 ± 3.4< 0.05
mean SUVpeak ± SD7.9 ± 4.05.6 ± 2.7< 0.05
mean mSUVmtv4.5 ± SD6.5 ± 1.55.5 ± 0.9< 0.05
Malignant/premalignant (n = 51)Benign (n = 32)P value
mean SUVmax ± SD11.6 ± 6.37.2 ± 3.4< 0.05
mean SUVpeak ± SD8.8 ± 5.15.6 ± 2.7< 0.05
mean mSUVmtv3.5 ± SD5.9 ± 1.64.7 ± 0.8< 0.05